• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估排尿荧光杂交技术对术前“低危”上尿路尿路上皮癌病理诊断的效能

Evaluation of the diagnostic efficiency of voided urine fluorescence hybridization for predicting the pathology of preoperative "low-risk" upper tract urothelial carcinoma.

作者信息

Xu Ben, Zhang Jia-En, Ye Lin, Yuan Chang-Wei

机构信息

Department of Urology, Peking University First Hospital, Beijing, China.

出版信息

Front Oncol. 2023 Jul 27;13:1225428. doi: 10.3389/fonc.2023.1225428. eCollection 2023.

DOI:10.3389/fonc.2023.1225428
PMID:37576882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10412927/
Abstract

OBJECTIVES

To evaluate the clinical utility of voided urine fluorescence hybridization (FISH) for predicting the pathology of preoperative "low-risk" upper tract urothelial carcinoma (UTUC).

METHODS

Information of patients preoperatively diagnosed with "low-risk" UTUC receiving radical nephroureterectomy (RNU) between May 2014 and October 2019 were retrospectively collected. All of the patients accepted the FISH test and then were divided into two groups according to the results of FISH. The diagnostic value of FISH was assessed through the receiver operating characteristics (ROC) curve and area under the curve. Logistic regression analysis was applied to examine FISH as a predictive factor of tumor final stage and grade of preoperative "low-risk" UTUC.

RESULTS

In total, 129 patients were included. Of them, 70 (54.2%) were marked with positive FISH result. The difference at final pathology in tumor stage and tumor grade between these two groups of FISH (-) and FISH (+) had significantly statistical significance (p<0.001). Regarding to the tumor stage at final pathology, the sensitivity, specificity, positive predictive value and negative predictive value of FISH were 70.7 (58.9-80.3)68.5 (54.3-80.1)75.7 (63.7-84.8) and 62.7 (49.1-74.7), respectively. Regarding to the tumor grade at final pathology, the sensitivity, specificity, positive predictive value and negative predictive value of FISH were 64.7 (53.5-74.6), 65.9 (50.0-79.1), 78.6 (66.8-87.1) and 49.1 (36.5-62.3), respectively. The results of logistic regression analysis indicated that FISH could predict the pathologic characteristics of preoperative "low-risk" UTUC independently.

CONCLUSIONS

FISH was qualified with relatively high diagnostic estimates for predicting tumor stage and grade of preoperative "low-risk" UTUC, and could be an independent predictive factor in clinical practice. For preoperative "low-risk" UTUC patients but with positive FISH result, choosing nephron-sparing surgery may require special caution.

摘要

目的

评估排尿尿液荧光原位杂交(FISH)对术前“低风险”上尿路尿路上皮癌(UTUC)病理情况的预测临床效用。

方法

回顾性收集2014年5月至2019年10月期间术前诊断为“低风险”UTUC并接受根治性肾输尿管切除术(RNU)的患者信息。所有患者均接受FISH检测,并根据FISH结果分为两组。通过受试者工作特征(ROC)曲线及曲线下面积评估FISH的诊断价值。应用逻辑回归分析检验FISH作为术前“低风险”UTUC肿瘤最终分期和分级预测因素的情况。

结果

共纳入129例患者。其中,70例(54.2%)FISH结果为阳性。FISH(-)组和FISH(+)组在肿瘤最终病理分期和分级方面的差异具有显著统计学意义(p<0.001)。对于最终病理的肿瘤分期,FISH的敏感性、特异性、阳性预测值和阴性预测值分别为70.7(58.9 - 80.3)、68.5(54.3 - 80.1)、75.7(63.7 - 84.8)和62.7(49.1 - 74.7)。对于最终病理的肿瘤分级,FISH的敏感性、特异性、阳性预测值和阴性预测值分别为64.7(53.5 - 74.6)、65.9(50.0 - 79.1)、78.6(66.8 - 87.1)和49.1(36.5 - 62.3)。逻辑回归分析结果表明,FISH可独立预测术前“低风险”UTUC的病理特征。

结论

FISH对术前“低风险”UTUC的肿瘤分期和分级具有较高的诊断评估价值,且在临床实践中可能是一个独立的预测因素。对于术前“低风险”UTUC患者但FISH结果为阳性者,选择保留肾单位手术可能需要特别谨慎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bccc/10412927/46cba46faa9f/fonc-13-1225428-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bccc/10412927/085f42ee9aac/fonc-13-1225428-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bccc/10412927/40c8b468d808/fonc-13-1225428-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bccc/10412927/46cba46faa9f/fonc-13-1225428-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bccc/10412927/085f42ee9aac/fonc-13-1225428-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bccc/10412927/40c8b468d808/fonc-13-1225428-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bccc/10412927/46cba46faa9f/fonc-13-1225428-g003.jpg

相似文献

1
Evaluation of the diagnostic efficiency of voided urine fluorescence hybridization for predicting the pathology of preoperative "low-risk" upper tract urothelial carcinoma.评估排尿荧光杂交技术对术前“低危”上尿路尿路上皮癌病理诊断的效能
Front Oncol. 2023 Jul 27;13:1225428. doi: 10.3389/fonc.2023.1225428. eCollection 2023.
2
Fluorescence in situ hybridization status of voided urine predicts invasive and high-grade upper tract urothelial carcinoma.排尿后尿液的荧光原位杂交状态可预测浸润性和高级别上尿路尿路上皮癌。
Oncotarget. 2017 Apr 18;8(16):26106-26111. doi: 10.18632/oncotarget.15344.
3
Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.荧光原位杂交(FISH)在膀胱和上尿路尿路上皮癌诊断中的应用:迄今为止最大规模的单机构经验。
Can J Urol. 2017 Feb;24(1):8620-8626.
4
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma.基于肿瘤分级和分期的预测模型在局限性上尿路上皮癌中的准确性和临床实用性。
Eur Urol Focus. 2022 May;8(3):761-768. doi: 10.1016/j.euf.2021.05.002. Epub 2021 May 27.
5
The Impact of Fluorescence in situ Hybridization on the Staging of Upper Tract Urothelial Carcinoma.荧光原位杂交技术在上尿路尿路上皮癌分期中的影响。
Urol Int. 2021;105(7-8):631-636. doi: 10.1159/000513459. Epub 2021 Feb 12.
6
Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.术前尿细胞学阳性预测行肾输尿管切除术的上尿路上皮癌患者临床结局不良。
BMC Cancer. 2020 Nov 16;20(1):1113. doi: 10.1186/s12885-020-07623-5.
7
Prospective evaluation of FISH for detecting upper tract urothelial carcinoma in voided urine specimens.荧光原位杂交技术用于检测晨尿标本中上尿路尿路上皮癌的前瞻性评估。
Oncol Lett. 2016 Jul;12(1):183-188. doi: 10.3892/ol.2016.4592. Epub 2016 May 17.
8
Diagnostic performance of an immunoassay based on urine exfoliated cell enrichment nanotechnology for upper tract urothelial carcinoma: a retrospective, monocentric study.基于尿液脱落细胞富集纳米技术的免疫测定对上尿路尿路上皮癌的诊断性能:一项回顾性、单中心研究。
BMC Urol. 2022 Nov 25;22(1):194. doi: 10.1186/s12894-022-01122-4.
9
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.荧光原位杂交(FISH)在上尿路尿路上皮癌(UTUC)中的诊断性能:系统评价和荟萃分析。
Int J Clin Oncol. 2022 Oct;27(10):1605-1615. doi: 10.1007/s10147-022-02216-7. Epub 2022 Jul 18.
10
Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study.1 毫升选择性尿液中的荧光原位杂交检测上尿路尿路上皮癌:一项可行性研究。
Med Oncol. 2018 Nov 29;36(1):10. doi: 10.1007/s12032-018-1237-x.

引用本文的文献

1
Diagnostic status and new explorations in upper urinary tract urothelial carcinoma: a literature review.上尿路尿路上皮癌的诊断现状与新探索:文献综述
Transl Androl Urol. 2024 Nov 30;13(11):2570-2586. doi: 10.21037/tau-24-326. Epub 2024 Nov 28.

本文引用的文献

1
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group.变异型组织学对上尿路上皮癌肿瘤学结局的影响:ROBUUST 协作组的研究结果。
Clin Genitourin Cancer. 2023 Oct;21(5):563-568. doi: 10.1016/j.clgc.2023.05.011. Epub 2023 May 24.
2
Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline.非转移性上尿路尿路上皮癌的诊断与管理:美国泌尿外科学会/泌尿外科学会指南
J Urol. 2023 Jun;209(6):1071-1081. doi: 10.1097/JU.0000000000003480. Epub 2023 Apr 25.
3
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.
欧洲泌尿外科学会上尿路尿路上皮癌指南:2023 年更新版。
Eur Urol. 2023 Jul;84(1):49-64. doi: 10.1016/j.eururo.2023.03.013. Epub 2023 Mar 24.
4
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review.具有变异组织学特征的非肌肉浸润性膀胱癌的诊断和治疗策略的影响:系统评价。
Minerva Urol Nephrol. 2023 Jun;75(3):278-288. doi: 10.23736/S2724-6051.23.05091-7. Epub 2023 Mar 22.
5
Diagnostic value of Xpert® BC Detection, Bladder Epicheck®, Urovysion® FISH and cytology in the detection of upper urinary tract urothelial carcinoma.Xpert® BC 检测、膀胱 Epicheck®、Urovysion® FISH 和细胞学在检测上尿路上皮癌中的诊断价值。
World J Urol. 2023 May;41(5):1323-1328. doi: 10.1007/s00345-023-04350-x. Epub 2023 Mar 16.
6
Variant histology in upper tract carcinomas: Analysis of the National Cancer Database.上尿路癌中的变异组织学:国家癌症数据库分析。
Urol Oncol. 2023 Apr;41(4):206.e1-206.e9. doi: 10.1016/j.urolonc.2023.01.017. Epub 2023 Feb 22.
7
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.根治性膀胱切除术治疗的尿路上皮膀胱癌中变异组织学的预后影响
BJU Int. 2023 Aug;132(2):170-180. doi: 10.1111/bju.15984. Epub 2023 Feb 20.
8
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.荧光原位杂交(FISH)在上尿路尿路上皮癌(UTUC)中的诊断性能:系统评价和荟萃分析。
Int J Clin Oncol. 2022 Oct;27(10):1605-1615. doi: 10.1007/s10147-022-02216-7. Epub 2022 Jul 18.
9
Variant histologies of urothelial carcinoma: Does it change the survival outcomes in patients managed with radical cystectomy?尿路上皮癌的异型组织学:在接受根治性膀胱切除术治疗的患者中,它是否改变了生存结局?
Arch Ital Urol Androl. 2022 Jun 29;94(2):138-143. doi: 10.4081/aiua.2022.2.138.
10
Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients With Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy.根治性肾输尿管切除术后上尿路尿路上皮癌患者膀胱内复发不良病理类型的危险因素
Front Oncol. 2022 Apr 13;12:834692. doi: 10.3389/fonc.2022.834692. eCollection 2022.